Disetronic/Ypsomed – over 40 years of success

In 1984, Disetronic was founded by the brothers Willy and Peter Michel, in Burgdorf, Switzerland. The successful company was the first one to introduce a micro insulin pump on the market. Besides its infusion systems, Disetronic specialised in injection systems. In 2003, the co-founder and main shareholder, Willy Michel, sold Disetronic with its infusion business to Roche. However, he kept the injection business. That is how Ypsomed was born. Ever since, Ypsomed has written its own success story. On 22 September 2004, Ypsomed got listed on SIX Swiss Exchange. Meanwhile, Ypsomed is back in the insulin pump business: from 2010 to 2018 as a distributor of the mylife OmniPod by Insulet and since 2016 with its own insulin pump, the mylife YpsoPump.

Co-founder and main shareholder Willy Michel appointed Honorary Chairman of the Ypsomed Group

Willy Michel was a member of the Group Management of Disetronic Holding AG until April 2003 and was non-executive Chairman of the Board of Directors of Ypsomed Holding AG from 2003 to August 2011. From August 2011 to June 2014, Willy Michel was Delegate of the Board of Directors and CEO of Ypsomed Holding AG and the Ypsomed Group. From July 2014 to June 2022, he served as non-executive Chairman of the Board of Directors of Ypsomed Holding AG.

In appreciation and gratitude for his lifelong, entrepreneurial and successful commitment and in recognition of his decades of service as a person with responsibility for Ypsomed and formerly Disetronic, Dr h.c. Willy Michel was appointed Honorary Chairman of the Board of Directors on 17 May 2022. Willy Michel was appointed Honorary Chairman of the Ypsomed Group by the Board of Directors on 17 May 2022, which is not associated with any function in a governing body.

Ypsomed milestones – a chronology

2023

Ypsomed Group

Ypsomed Diabetes Care

Ypsomed Delivery Systems

2022

Ypsomed Group

Ypsomed Diabetes Care

Ypsomed Delivery Systems

2021

Ypsomed Group

Ypsomed Diabetes Care

Ypsomed Delivery Systems

2020

Ypsomed Group

Ypsomed Diabetes Care

Ypsomed Delivery Systems

2019

Ypsomed Group

  • In the USA, Ypsomed founds its subsidiary.
  • In Schwerin, Germany, Ypsomed opens the world's most modern production site for medical products.
  • In Burgdorf and Solothurn, Switzerland, Ypsomed expands its office capacities.

Ypsomed Diabetes Care

  • The mylife YpsoPump insulin pump is launched in Canada, Croatia, Ireland and Bulgaria.

Ypsomed Delivery Systems

  • With YDS SmartServices, Ypsomed offers its customers complete digital solutions.
  • Based on the YpsoMate autoinjector, the Copaxone Pen is launched by Teva.
2018

Ypsomed Group

  • In Denmark, Finland and Norway, Ypsomed founds its subsidiaries.
  • In Burgdorf, Switzerland, the new laboratory and the new tool manufacturing are put into operation.

Yposmed Diabetes Care

  • The mylife YpsoPump insulin pump is launched in Sweden, Denmark, Austria, Finland, Poland, Belgium, Spain and Australia.
  • They mylife OmniPod business is properly transferred to Insulet.
  • The mylife Unio Neva blood glucose monitoring system with its automated data transfer to the mylife App is launched.
  • The mylife App with integrated bolus calculator is available for download in the Apple App Store.

Ypsomed Delivery Systems

  • With the PLAJEX syringe with Hulio by Terumo, an YpsoMate based autoinjector is commercially launched for the first time.
2017

Ypsomed Group

  • In Canada, Ypsomed founds its first North American subsidiary.
  • In Belgium, Poland and Spain, Ypsomed founds its subsidiary.
  • In Schwerin, Germany, Ypsomed starts with the construction of the new production site for injection and infusion systems.
  • In Solothurn, Switzerland, Ypsomed commissions a new production line for various injection systems.

Ypsomed Diabetes Care

  • The mylife YpsoPump insulin pump is launched in France, the Czech Republic, Switzerland and Italy.
  • The mylife App with integrated blous calculator is available for download in the Google Play Store.

Ypsomed Delivery Systems

  • Based on the UnoPen, the TYMLOS pen with abaloparatide is launched by Radius.
  • Based on the UnoPen, the GLARIN insulin pen is launched by Koçak.
  • Based on the YpsoPen, the insulin pen INSUPen Pro is launched by Biocon.
2016

Ypsomed Group

  • In Australia, Ypsomed founds its subsidiary.
  • Ypsomed and Novo Nordisk agree on a cooperation for the mylife YpsoPump in combination with the NovoRapid PumpCart.

Ypsomed Diabetes Care

  • The mylife YpsoPump insulin pump is launched in Germany, UK and the Netherlands.
  • The mylife Software for simple therapy management is launched.

Ypsomed Delivery Systems

  • Based on the ServoPen, the RinsaPen insulin pen is launchey by Geropharm.
2015

Ypsomed Group

  • In China, Ypsomed founds its subsidiary.

Ypsomed Diabetes Care

  • The mylife Clickfine DiamondTip pen needle with 6 bevel tip is launched.
  • The mylife Clickfine AutoProtect 5 mm / 31G needle is launched.

Ypsomed Delivery Systems

  • Based on the YpsoPen, the Lupisulin insulin pen is launched by Lupin.
  • Based on the YpsoPen, the PolhuminPen insulin pen is launched by Polfa Tarchomin.
  • Based on the YpsoPen, the id Pen for insulin is launched by Indar.
  • With the BiomatikPen 2 insulin pen by Pharmastandard, an UnoPen based product is launched for the first time.
2014

Ypsomed Group

  • Simon Michel takes over the position of CEO from Willy Michel.

Ypsomed Delivery Systems

  • The Albiglutide LyoTwist is launched by GlaxoSmithKline.
  • With the Bydureon Pen for GLP-1 by AstraZeneca, a product based on the LyoTwist platform is launched for the first time.

 

2013

Ypsomed Group

  • In Italy, Ypsomed founds its subsidiary.

Ypsomed Diabetes Care

  • The mylife Clickfine 4 mm / 32G needle is launched.
  • The mylife Penfine Classic needle with the twist is launched.
  • Ypsomed wins the Red Dot Design Award for mylife Unio.
  • The mylife Unio blood glucose monitoring system and the mylife AutoLance are launched.
  • The mylife Orbit Reservoir is launched.

Ypsomed Delivery Systems

  • First clinical trials are carried out for the YpsoMate autoinjector.
  • Based on the ServoPen, the Lupisulin Pen insulin pen is launched by Lupin.
  • Based on the YpsoPen, the Sulin insulin pen is launched by Dongbao.
  • Based on the YpsoPen, the Biosulin insulin pen is launched by MJ Biopharm.
2012

Ypsomed Group

  • In Austria, Ypsomed founds its subsidiary.

Ypsomed Diabetes Care

  • The mylife DailyDose self-injection system is launched.
  • The second generation of the mylife OmniPod insulin patch pump is launched.

Ypsomed Delivery Systems

  • Based on the ServoPen, the AnsuPen insulin pen is launched by Square.
  • Based on the ServoPen, the ConviPen insulin pen is launched by Incepta.
2011

Ypsomed Group

  • Ypsomed acquires the infusion business Orbit from ICU Medical, USA.

Ypsomed Diabetes Care

  • The Orbit infusion set for Luer-based insulin pumps is launched.
  • The mylife SafetyLancets are launched.

Ypsomed Delivery Systems

  • The umbrella brand Ypsomed Delivery Systems (YDS) is launched.
  • Based on the ServoPen, the Omnifill insulin pen is launched by B. Braun.
2010

Ypsomed Group

  • In UK, Ypsomed founds its subsidiary.

Ypsomed Diabetes Care

  • They mylife OmniPod insulin patch pump is launched.
  • The second generation of the mylife "click-on" safety pen needles is launched.
  • Ypsomed wins the Good Design Award for its Clickfine AutoProtect pen needles.

Ypsomed Delivery Systems

  • With the Gansulin insulin pen by Dongbao, a ServoPen based product, is launched for the first time.
  • The disposable pen Genotropin GoQuick with hGH is launched by Pfizer.
  • The BiomatikPen insulin pen is launched by Pharmstandard.
2009

Ypsomed Group

  • Ypsomed buys 10 % of shares in Bionime Corp., Taiwan.

Ypsomed Diabetes Care

  • The umbrella brand mylife Diabetescare is launched.
  • The mylife Pura blood glucose monitoring system is launched.

Ypsomed Delivery Systems

  • Ypsomed manufactures components for the SoloStar pen of Sanofi-Aventis.
  • Ypsomed wins the Red Dot Design Award for its ServoPen platform.
2008

Ypsomed Group

  • In India, Ypsomed founds its subsidiary.
  • In Burgdorf, Switzerland, Ypsomed opens the new Ypsomed logistics and manufacturing site.

Ypsomed Delivery Systems

  • The disposable SymlinPen is launched by Amylin Pharmaceuticals.
  • The YpsoPen Polfa insulin pen is launched by Polfa Tarchomin.
2007

Ypsomed Group

  • In Germany, Ypsomed acquires various diabetes sales organisations.

Ypsomed Delivery Systems

  • The reusable HumatroPen 3 with hGH is launched by Eli Lilly.
2006

Ypsomed Group

  • In Solothurn, Switzerland, Ypsomed acquires a new production site.
  • In Japan, Ypsomed is certified as foreign manufacturer.

Ypsomed Delivery Systems

  • The Preotact Pen for PTH is launched by Nycomed.
  • The Dongbao electronic insulin pen is launched by Dongbao.
2005

Ypsomed Group

  • In the Czech Republic, Ypsomed founds its subsidiary.

Ypsomed Delivery Systems

  • The world's first semi-disposable injection system for insulin, the OptiClik pen system, is launched by Sanofi-Aventis.
2004

Ypsomed Group

  • Ypsomed is listed on the Swiss Stock Exchange.

Ypsomed Delivery Systems

  • The disposable Gonal-f Pen for FSH is launched by Merck-Serono.
2003

Ypsomed Group

  • Ypsomed sells Disetronic's insulin pump business to Roche.
  • In Germany, Ypsomed founds the mail-order business company DiaExpert,
  • Disetronic is renamed Ypsomed.

Ypsomed Delivery Systems

  • The Genotropin Pen with hGH is launched by Pharmacia & Upjohn.